The US Food and Drug Administration (FDA) has approved Duzallo (Ironwood Pharmaceuticals), a fixed-dose oral combination of lesinurad (Zurampic, AstraZeneca) and allopurinol (multiple brands), for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback